Minneapolis, MN, United States of America

Ning Xie

This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ning Xie. Retrieved from https://idiyas.com/inventor/ning-xie-0n3cyiwp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ning Xie: Innovator in Fibroadipogenic Progenitor Cell Production

Introduction

Ning Xie is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of cell biology, particularly in the production of fibroadipogenic progenitor cells. His innovative methods have the potential to advance research and applications in regenerative medicine.

Latest Patents

Ning Xie holds a patent titled "Methods for producing fibroadipogenic progenitor cells." This patent outlines methods for producing a preparation of fibroadipogenic progenitors (FAPs) from a cell mixture. In certain embodiments, the patent describes a method of producing a preparation of human FAPs from a skeletal muscle biopsy sample for later use. This work is crucial for understanding and utilizing FAPs in various medical applications.

Career Highlights

Ning Xie is affiliated with the University of Minnesota, where he conducts his research and development. His work has garnered attention for its innovative approach to cell production and its implications for future medical therapies.

Collaborations

Ning collaborates with esteemed colleagues, including Michael Kyba and Natalya Goloviznina. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in their field.

Conclusion

Ning Xie's contributions to the production of fibroadipogenic progenitor cells represent a significant advancement in cell biology. His innovative methods and collaborations with other experts continue to pave the way for future research and applications in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…